Aadi Bioscience, Inc. (AADI) Tops Q2 EPS by 15c
Tweet
Share
E-mailGet Alerts AADI Hot Sheet
Join SI Premium – FREE
Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q2 EPS of ($0.54), $0.15 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $6.2 million versus the consensus estimate of $6.19 million.
For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westport Fuel Systems (WPRT) Misses Q2 EPS by 64c
- Pliant Therapeutics, Inc. (PLRX) Misses Q2 EPS by 2c
- Optex Systems Holdings, Inc. (OPXS) Misses Q3 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
